spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech, and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focusses on key trends, concerns, and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.

For further information please contact:

Advertising
George Briggs

Editorial
Joel Emmons

We're also on Twitter! Follow us @EPCmagazine


Click here to view the digital
version of EPC


 

  

Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

   
epc
 
 
Featured in this issue
Clinical data
From EDC to eSource

Overcoming the Industry's Data Crisis

With an industry-wide aim for improved data collection, Ed Seguine at Clinical Ink discusses the current view that pharma is locked in an innovation paradox.
Clinical data
Clinical Trial Data Capture

The Changing Face of Clinical Data

Clinical data can take many forms, and the way we collect and analyse these data is evolving, explains Aiden Flynn at Exploristics.
  Clinical data
Real-World Evidence in Drug Development

Fit for Purpose

IQVIA Biotech’s Marni Hall and Nicola Stanislaus evaluate the framework of real-world evidence application in clinical trials and the coordinated efforts of pharmaceutical companies and regulatory bodies.

spacer



Published quarterly in
February, May,
August, and November


 

Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

air transport logo

 

White Papers

Interface: Drug Delivery Devices

Phillips-Medisize

A family is packing for its annual summer trek to the cottage by the lake. Along with fishing gear, sunscreen, and life vests, the checklist also includes another kind of life saver – an autoinjector that delivers two doses of epinephrine to treat anaphylaxis, a severe and potentially lifethreatening allergic reaction.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement